Anatomic Pathology Market Size, Share & Trends Analysis Report 2021 - 2028
Anatomic Pathology Industry Overview
The global anatomic pathology market size was valued at USD 16.06 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.08% from 2021 to 2028. An increase in the clinical use of biomarkers enables the pathologists to determine disease pathogenesis at the molecular level and further guides the clinical decision-making, thereby improving patient outcomes. The growing reliance on biomarkers-based pathology tests and procedures to explore common malignancy and tumorigenesis is driving the market. The COVID-19 pandemic is serving as a driver for the adoption of whole slide imaging, digital pathology, and telepathology. Digital pathology has helped pathologists work remotely, enhancing their overall productivity and helping them address the backlog of cases. The usage rate of these technologies has been gaining momentum over the past few years. The COVID-19 pandemic has further boosted this adoption, in turn, having a positive impact on the market growth.
The high usage of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes is poised to improve anatomic pathological practices to a major extent. The digital imaging solutions offer specificity and accuracy-related benefits over the conventional techniques, which in turn, boosts the service uptake rate in the market for anatomic pathology.
Gather more insights about the market drivers, restrains and growth of the Global Anatomic Pathology market
Companies are undertaking continuous efforts for the development of advanced and upgraded pathology equipment with respect to their design and ease of use. For instance, in May 2021, a digital pathology solutions provider-OptraSCAN introduced CytoSiA-an intelligent solution for affordable and rapid scanning and analysis of pap smears and liquid-based cytology slides. This instrument allows whole slide cytology imaging with advanced image analysis.
Moreover, several partnership and agreement ventures among key companies for the introduction of an effective portfolio are driving the market. For instance, in April 2021, Royal Philips collaborated with Ibex Medical Analytics, a company involved in AI-based cancer diagnostics, to boost the adoption of AI-based digital pathology. Both the companies combined their expertise to offer advanced solutions to empower pathologists.
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
- Biopsy Devices Market - The global biopsy devices market size was estimated at USD 1.0 billion in 2016. Growing prevalence of cancer worldwide and the presence of untapped opportunities in emerging economies, especially of Asia Pacific, along with improving healthcare infrastructure in these regions are among the key trends stoking market growth. Surging demand for effective diagnostic procedures for cancer is also expected to work in favor of the market.
- Vitamin D Testing Market - The global vitamin D testing market size was estimated at USD 498.1 million in 2016. Global rise in geriatric population coupled with increase in chronic illnesses, such as type 2 diabetes, kidney disease, Crohn's disease, and celiac disease, is anticipated to drive the growth of the market.
Anatomic Pathology Market Segmentation
Grand View Research has segmented the global anatomic pathology market on the basis of product and services, application, end-use, and region:
Anatomic Pathology Product & Services Outlook (Revenue, USD Million, 2017 - 2028)
- Instruments
- Consumables
- Services
Anatomic Pathology Application Outlook (Revenue, USD Million, 2017 - 2028)
- Disease Diagnosis
- Drug Discovery and Development
- Others
Anatomic Pathology End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Anatomic Pathology Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Market Share Insights
- September 2021: Roche announced the launch of digital pathology open environment. The new workflow allows researchers and physicians to share images for better analysis. Further, the platform is compatible with whole slide imaging technology.
Key Companies profiled:
Some prominent players in the global Anatomic Pathology market include
- Danaher Corporation
- PHC Holdings Corporation
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Hoffmann-La Roche AG
- Agilent Technologies, Inc.
- Cardinal Health
- Sakura Finetek USA, Inc.
- NeoGenomics Laboratories, Inc.
- BioGenex
- Bio SB
Order a free sample PDF of the Anatomic Pathology Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment